Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors
Novel Anti-Cancer therapies
CUDC-101 (HDAC/EGFR/Her2 inhibitor) & HSP90 Debio-0932 (CUDC-305)
News 
Site map
-
- Forum
- Topics
- Posts
- Last post
-
-
CUDC-101 (HDAC/EGFR/Her2 inhibitor)
Topics surrounding a novel approach to fighting cancers News Site map 
RSS Feed 
Sitemap
- 2 Topics
- 2 Posts
-
Last postCUDC-101 Medicinal ...
by hedgehog
Sat Feb 27, 2010 4:12 pm
-
CUDC-101 (HDAC/EGFR/Her2 inhibitor)
-
-
HSP90 Debio-0932 (CUDC-305)
Debio 0932 (formerly CUDC-305) is a small molecule inhibitor of Heat Shock Protein 90 (Hsp90). Debio0932 is expected to enter Phase I clinical testing in early Q1 2010. News Site map RSS Feed Sitemap
- 2 Topics
- 3 Posts
-
Last postAbout Debio-0932 ...
by hedgehog
Fri Feb 19, 2010 2:27 pm
-
-
- Active topics
- Replies
- Views
- Last post
-
- About Debio-0932 (CUDC-305)
by hedgehog » Thu Feb 11, 2010 5:12 pm - 1 Replies
- 182 Views
- Last post by hedgehog
Fri Feb 19, 2010 2:27 pm
- About Debio-0932 (CUDC-305)
-
- How Does CUDC-101 Work?
by hedgehog » Mon Feb 08, 2010 8:36 am - 0 Replies
- 140 Views
- Last post by hedgehog
Mon Feb 08, 2010 8:36 am
- How Does CUDC-101 Work?
-
- CUDC-101 Medicinal Chemistry Information
by hedgehog » Sat Feb 27, 2010 4:12 pm - 0 Replies
- 113 Views
- Last post by hedgehog
Sat Feb 27, 2010 4:12 pm
- CUDC-101 Medicinal Chemistry Information
-
- CUDC-305 / Debio HSP90 overcomes erlotinib resistance
by hedgehog » Thu Feb 11, 2010 5:16 pm - 0 Replies
- 125 Views
- Last post by hedgehog
Thu Feb 11, 2010 5:16 pm
- CUDC-305 / Debio HSP90 overcomes erlotinib resistance
Who is online
Users browsing this forum: No registered users and 1 guest
